Cargando…

Dual Contraceptive Use and Associated Factors Among Reproductive Age Group on Antiretroviral Therapy in Borena District, Northeast Ethiopia: A Cross-Sectional Study

BACKGROUND: Dual contraceptive method use is defined as the use of any modern contraceptive method with a condom for the reduction of mother-to-child transmission of HIV and sexually transmitted infections between sexual partners. The goal of this study was to assess the proportion and factors assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Amare, Gashaw, Cherie, Niguss, Mekonen, Asnakew Molla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847380/
https://www.ncbi.nlm.nih.gov/pubmed/33531844
http://dx.doi.org/10.2147/HIV.S289045
_version_ 1783644921372082176
author Amare, Gashaw
Cherie, Niguss
Mekonen, Asnakew Molla
author_facet Amare, Gashaw
Cherie, Niguss
Mekonen, Asnakew Molla
author_sort Amare, Gashaw
collection PubMed
description BACKGROUND: Dual contraceptive method use is defined as the use of any modern contraceptive method with a condom for the reduction of mother-to-child transmission of HIV and sexually transmitted infections between sexual partners. The goal of this study was to assess the proportion and factors associated with dual contraceptive use among reproductive age women on antiretroviral therapy in Borena district, Northeast Ethiopia. OBJECTIVE: To assess the proportion of dual contraceptive use and associated factors among the reproductive age women on antiretroviral therapy in Borena district, Northeast Ethiopia. METHODS: An institutional-based cross-sectional study was conducted among HIV positive reproductive age group women on antiretroviral therapy in Borena district from February 1 to March 1, 2020. A systematic random sampling technique was used to include 417 study participants. A structured interviewer-administered questionnaire was used to collect the data. A binary logistic regression model was used to identify the factors associated with dual contraceptive use. Odds ratio with 95% confidence interval (CI) and P-value were calculated to assess the strength of association. RESULTS: The results showed that 19.4% of the HIV positive reproductive age group on antiretroviral therapy were using dual contraceptive method. Urban area (AOR=3.66, 95% CI=1.66–8.09), educated to secondary education and above (AOR=3.54, 95% CI=1.29–9.76), those who have no desire to have a child (AOR=4.41, 95% CI=2.66–7.59), those with partners whose HIV status was negative (AOR=4.96, 95% CI=2.66–12.02) and those with partners whose HIV status was positive (AOR=2.45, 95% CI=1.25–4.81) were more likely to use the dual contraception method. CONCLUSION: This study showed that the proportion of dual contraceptive use was found to be low in accordance with the WHO recommendation. Therefore increased awareness on the advantages of dual contraception and knowing partner's HIV status is important.
format Online
Article
Text
id pubmed-7847380
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78473802021-02-01 Dual Contraceptive Use and Associated Factors Among Reproductive Age Group on Antiretroviral Therapy in Borena District, Northeast Ethiopia: A Cross-Sectional Study Amare, Gashaw Cherie, Niguss Mekonen, Asnakew Molla HIV AIDS (Auckl) Original Research BACKGROUND: Dual contraceptive method use is defined as the use of any modern contraceptive method with a condom for the reduction of mother-to-child transmission of HIV and sexually transmitted infections between sexual partners. The goal of this study was to assess the proportion and factors associated with dual contraceptive use among reproductive age women on antiretroviral therapy in Borena district, Northeast Ethiopia. OBJECTIVE: To assess the proportion of dual contraceptive use and associated factors among the reproductive age women on antiretroviral therapy in Borena district, Northeast Ethiopia. METHODS: An institutional-based cross-sectional study was conducted among HIV positive reproductive age group women on antiretroviral therapy in Borena district from February 1 to March 1, 2020. A systematic random sampling technique was used to include 417 study participants. A structured interviewer-administered questionnaire was used to collect the data. A binary logistic regression model was used to identify the factors associated with dual contraceptive use. Odds ratio with 95% confidence interval (CI) and P-value were calculated to assess the strength of association. RESULTS: The results showed that 19.4% of the HIV positive reproductive age group on antiretroviral therapy were using dual contraceptive method. Urban area (AOR=3.66, 95% CI=1.66–8.09), educated to secondary education and above (AOR=3.54, 95% CI=1.29–9.76), those who have no desire to have a child (AOR=4.41, 95% CI=2.66–7.59), those with partners whose HIV status was negative (AOR=4.96, 95% CI=2.66–12.02) and those with partners whose HIV status was positive (AOR=2.45, 95% CI=1.25–4.81) were more likely to use the dual contraception method. CONCLUSION: This study showed that the proportion of dual contraceptive use was found to be low in accordance with the WHO recommendation. Therefore increased awareness on the advantages of dual contraception and knowing partner's HIV status is important. Dove 2021-01-26 /pmc/articles/PMC7847380/ /pubmed/33531844 http://dx.doi.org/10.2147/HIV.S289045 Text en © 2021 Amare et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Amare, Gashaw
Cherie, Niguss
Mekonen, Asnakew Molla
Dual Contraceptive Use and Associated Factors Among Reproductive Age Group on Antiretroviral Therapy in Borena District, Northeast Ethiopia: A Cross-Sectional Study
title Dual Contraceptive Use and Associated Factors Among Reproductive Age Group on Antiretroviral Therapy in Borena District, Northeast Ethiopia: A Cross-Sectional Study
title_full Dual Contraceptive Use and Associated Factors Among Reproductive Age Group on Antiretroviral Therapy in Borena District, Northeast Ethiopia: A Cross-Sectional Study
title_fullStr Dual Contraceptive Use and Associated Factors Among Reproductive Age Group on Antiretroviral Therapy in Borena District, Northeast Ethiopia: A Cross-Sectional Study
title_full_unstemmed Dual Contraceptive Use and Associated Factors Among Reproductive Age Group on Antiretroviral Therapy in Borena District, Northeast Ethiopia: A Cross-Sectional Study
title_short Dual Contraceptive Use and Associated Factors Among Reproductive Age Group on Antiretroviral Therapy in Borena District, Northeast Ethiopia: A Cross-Sectional Study
title_sort dual contraceptive use and associated factors among reproductive age group on antiretroviral therapy in borena district, northeast ethiopia: a cross-sectional study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847380/
https://www.ncbi.nlm.nih.gov/pubmed/33531844
http://dx.doi.org/10.2147/HIV.S289045
work_keys_str_mv AT amaregashaw dualcontraceptiveuseandassociatedfactorsamongreproductiveagegrouponantiretroviraltherapyinborenadistrictnortheastethiopiaacrosssectionalstudy
AT cherieniguss dualcontraceptiveuseandassociatedfactorsamongreproductiveagegrouponantiretroviraltherapyinborenadistrictnortheastethiopiaacrosssectionalstudy
AT mekonenasnakewmolla dualcontraceptiveuseandassociatedfactorsamongreproductiveagegrouponantiretroviraltherapyinborenadistrictnortheastethiopiaacrosssectionalstudy